Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01634789 · ClinicalTrials.gov registry record · Phase 1
A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women
A Phase 1 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT01634789 is a Phase 1 study that was terminated before completion, run by Pfizer. The registered enrollment target is 2 participants.
The verdict
NCT01634789, a Phase 1 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate 3 test formulations relative to a reference formulation.
Interventions
- DRUG bazedoxifene
- DRUG bazedoxifene/conjugated estrogens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-08 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01634789
The ClinicalTrials.gov registry entry for NCT01634789 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which bazedoxifene is the first listed.
NCT01634789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01634789 about?
NCT01634789 is a clinical study titled "A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women". The purpose of this study is to evaluate 3 test formulations relative to a reference formulation.
What is the current status of trial NCT01634789?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2012-08. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01634789?
The interventions under investigation include: bazedoxifene (DRUG), bazedoxifene/conjugated estrogens (DRUG).
Who is sponsoring clinical trial NCT01634789?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.